Overall survival (OS) according to −7 subgroups. Patients with −7 and inv(3), del(5q)/−5, or +21 had an OS of 5%. OS in the remaining group of patients with −7 other (excluding inv(3), del(5q)/−5, +21) was 34% and in the patients with −7 only OS was 34%.